Menu

Blog

Archive for the ‘biotech/medical’ category: Page 152

Sep 7, 2023

Nanobots can now enter brain cells to spy on what they’re doing

Posted by in categories: biotech/medical, genetics, nanotechnology, robotics/AI

The ability to cure all disease slowly comes in view. ANI into Agi into ASI needs to be primary focus. Followed by genetics research, and lastly an extreme focus on Medical Nanobots. ASI will of cured most diseases by 2035–2040.


Fleets of advanced versions may one day be able to detect disease and then go about surgically treating it — without ever opening the skull.

Sep 7, 2023

You can now make an AI clone of yourself — or anyone else, living or dead — with Delphi

Posted by in categories: biotech/medical, mobile phones, robotics/AI

Imagine talking to einstein or Stephen Hawking 😗😁.


Head over to our on-demand library to view sessions from VB Transform 2023. Register Here

My favorite episode of the hit sci-fi/horror TV series Black Mirror is “Be Right Back,” which premiered 10 years ago now, and captured the alienating experience of a woman cloning her dead ex-boyfriend by using a service that analyzed his social media posts and texts to recreate his personality.

Continue reading “You can now make an AI clone of yourself — or anyone else, living or dead — with Delphi” »

Sep 7, 2023

Gut Microbiome Flaws Linked to Allergies from Food to Eczema

Posted by in categories: biotech/medical, food, health

A study has linked the development in kids of any of food allergy, asthma, eczema and rhinitis to a common factor – an unbalanced gut microbiome.

Researchers have long been intrigued by the gut microbiome in the development of allergic diseases. But this Canadian study is unique in identifying a common origin in infancy across the four separate allergic diseases. As well, it explored the composition of gut bacteria in children before and following allergic sensitization.

As each allergic disease has a separate list of symptoms, they are usually studied on their own. “But when you look at what is going wrong at a cellular level, they actually have a lot in common,” notes Dr. Charisse Petersen, co-senior author and a researcher at BC Children’s Hospital Research Institute and BC Children’s Hospital.

Sep 6, 2023

Accelerating retail personalization at scale

Posted by in category: biotech/medical

Today’s retailers are faced with a clear opportunity for transformation. Consumer expectations are constantly evolving, challenging retailers to keep pace. A blend of online and in-person shopping forged during the pandemic persists, forcing retailers to deliver a highly personalized omnichannel experience. And retailers’ values are becoming as important to consumers as their products and services.

Sep 6, 2023

Clovibactin — a game-changing novel antibiotic with no resistance

Posted by in category: biotech/medical

Researchers reported the discovery of a new antibiotic, clovibactin.

Sep 6, 2023

AI builds momentum for smarter health care

Posted by in categories: biotech/medical, business, health, robotics/AI

The pharmaceutical industry operates under one of the highest failure rates of any business sector. The success rate for drug candidates entering capital Phase 1 trials—the earliest type of clinical testing, which can take 6 to 7 years —is anywhere between 9% and 12%, depending on the year, with costs to bring a drug from discovery to market ranging from $1.5 billion to $2.5 billion, according to Science.

Sep 6, 2023

How FBI remotely deleted QBot malware from 700K computers worldwide

Posted by in categories: biotech/medical, cryptocurrencies, cybercrime/malcode, finance, government, law enforcement

The United States government said today that a multinational law enforcement operation has destroyed Qakbot, also known as QBot, an infamous botnet and malware loader that was responsible for losses that amounted to hundreds of millions of dollars all over the globe, and that they have confiscated more than $8.6 million in illegal cryptocurrencies.

During a news conference held on Tuesday to announce the takedown of the botnet, United States Attorney Martin Estrada referred to the investigation as “the most significant technological and financial operation ever led by the Department of Justice against a botnet.” Duck Hunt was headed by the FBI. For one thing, the federal government developed some software that, when installed on computers that were infected with Qbot, would make the virus useless.

Continue reading “How FBI remotely deleted QBot malware from 700K computers worldwide” »

Sep 6, 2023

Engineered Antibody Could Prevent Organ Rejection After Transplant

Posted by in category: biotech/medical

While other therapeutics have helped people and other animals avoid organ rejection, this one appears to trigger fewer dangerous side effects.

Sep 6, 2023

Kitalys Institute: breaking down the barriers to longevity clinical trials

Posted by in categories: biotech/medical, life extension

“Preserve health, prevent disease, prolong healthspan,” begins the mission statement of the Kitalys Institute. Lofty goals indeed from the not-for-profit organisation behind the annual Targeting Metabesity conference and a range of initiatives to translate longevity science into genuine public health gains.

Longevity. Technology: The vast majority of companies developing therapeutics in the longevity field are adopting strategies that involve targeting specific indications rather than aging itself. And well they might, because there is currently no precedent for drugs targeting aging at regulatory bodies like the FDA. Kitalys wants to change that, and we caught up with the institute’s founder Dr Alexander “Zan” Fleming to find out more.

An endocrinologist by training, Fleming is well qualified to take on the regulators. He spent more than a decade at the FDA, where he led the medical reviews that resulted in approval of drugs including metformin, as well as the first statin, insulin analogue and PPAR agonist.

Sep 6, 2023

Tattoo technique transfers gold nanopatterns onto live cells

Posted by in categories: biotech/medical, chemistry, cyborgs, nanotechnology, neuroscience, transhumanism

For now, cyborgs exist only in fiction, but the concept is becoming more plausible as science progresses. And now, researchers are reporting in ACS’ Nano Letters that they have developed a proof-of-concept technique to “tattoo” living cells and tissues with flexible arrays of gold nanodots and nanowires. With further refinement, this method could eventually be used to integrate smart devices with living tissue for biomedical applications, such as bionics and biosensing.

Advances in electronics have enabled manufacturers to make integrated circuits and sensors with nanoscale resolution. More recently, laser printing and other techniques have made it possible to assemble flexible devices that can mold to curved surfaces. But these processes often use harsh chemicals, high temperatures or pressure extremes that are incompatible with living cells. Other methods are too slow or have poor spatial resolution. To avoid these drawbacks, David Gracias, Luo Gu and colleagues wanted to develop a nontoxic, high-resolution, lithographic method to attach nanomaterials to living tissue and cells.

The team used nanoimprint lithography to print a pattern of nanoscale gold lines or dots on a polymer-coated silicon wafer. The polymer was then dissolved to free the gold nanoarray so it could be transferred to a thin piece of glass. Next, the gold was functionalized with cysteamine and covered with a hydrogel layer, which, when peeled away, removed the array from the glass. The patterned side of this flexible array/hydrogel layer was coated with gelatin and attached to individual live fibroblast cells. In the final step, the hydrogel was degraded to expose the gold pattern on the surface of the cells. The researchers used similar techniques to apply gold nanoarrays to sheets of fibroblasts or to rat brains. Experiments showed that the arrays were biocompatible and could guide cell orientation and migration.

Page 152 of 2,414First149150151152153154155156Last